MedElevator Войти в исследования
← Поиск публикаций

DOI 10.5588/ijtld.15.0283

Медицинская библиотека · The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2016

Risk of developing active tuberculosis in rheumatoid arthritis patients on adalimumab in Japan.

Watanabe A, Matsumoto T, Igari H, Sawa J, Yamaguchi Y, Sakatani M

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

SETTING

Nationwide study in Japan.

OBJECTIVE

To identify the clinical characteristics of and risk factors for tuberculosis (TB) in rheumatoid arthritis (RA) patients receiving adalimumab.

DESIGN

A post hoc case-control study involving 7755 RA patients evaluated in an all-case post-marketing surveillance of adalimumab from 18 June 2008 to 20 January 2011 and spontaneous report of TB during adalimumab treatment.

RESULTS

The analysis included 22 TB cases and 7733 non-TB controls. Despite the high frequency of extra-pulmonary TB (17/22, 77.3%), all 22 TB cases had pulmonary signs or symptoms. Of patients enrolled in all-case post-marketing surveillance, there were relatively high percentages of patients who had latent tuberculous infection (LTBI) at baseline. The percentage of patients who received prophylaxis was about six times higher in patients with LTBI than those without. Of those patients who received prophylaxis, none developed TB after treatment with adalimumab. Multivariate (non-matched and age-matched) and propensity score analyses identified age ⩾65 years (OR 4.59, 95%CI 1.52-13.89, P = 0.0070), moderate to severe RA (OR 4.61, 95%CI 1.07-20.00, P = 0.0408], past or current renal dysfunction (OR 4.65, 95%CI 1.47-14.71, P = 0.0089) and diabetes mellitus (OR 3.30, 95%CI 1.31-8.26, P = 0.0110) as potential risk factors for TB.

CONCLUSION

Screening, prophylaxis and monitoring for TB are essential to ensure the safety of adalimumab treatment.

Для цитирования: Watanabe A, Matsumoto T, Igari H, Sawa J, Yamaguchi Y, Sakatani M. Risk of developing active tuberculosis in rheumatoid arthritis patients on adalimumab in Japan.. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 2016. DOI: 10.5588/ijtld.15.0283.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.